Association between thyroid feedback quartile index and FIB-4-defined fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, and treated primary hypothyroidism: an exploratory cross-sectional study.
文献摘要
Background Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) frequently coexists with Type 2 Diabetes Mellitus (T2DM) and Primary Hypothyroidism (PH); nevertheless, the relationship between thyroid hormone sensitivity and FIB-4-defined fibrosis risk across these metabolic diseases is yet unknown. Methods In 102 patients with MASLD, MASLD+T2DM, and MASLD+T2DM+treated PH (34 per group), this exploratory cross-sectional study examined the association between the Thyroid Feedback Quantile Index (TFQI) and the Fibrosis-4 Index (FIB-4). The cumulative distribution functions of TSH and FT4 were used to calculate TFQI. A surrogate indicator of the risk of fibrosis was FIB-4. G*Power 3.1.9.7 was used for post-hoc power analysis after multivariable regression and correlation analyses were completed. Results In the MASLD-alone group, TFQI and FIB-4 had a significant inverse correlation in unadjusted analysis ( r = -0.384, P = 0.025). Nevertheless, after controlling for age, sex, and BMI, this link was diminished and no longer significant ( β = -0.195, P = 0.073). The most powerful independent predictor of FIB-4 was age ( β = 0.704, P Conclusions Age played a major role in explaining the inverse correlation between TFQI and FIB-4 in patients with MASLD alone in this exploratory study. These results should be considered hypothesis-generating and should be validated in bigger prospective trials with direct measurements of fibrosis. Future research may benefit from the heterogeneous associations across metabolic backgrounds.